Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis
J Exp Med (2000) 192 (4): 463–474.
Currently there are no citedby results. Try again later.
